PharmEnable raised €6.9M in a Seed round in May 2023. The company is based in Cambridge, UK. Investors in the round: Arrowfield Capital, Cambridge Enterprise, Heyford Trust and 5 others. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
